Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow.
Santini G, De Souza C, Congiu AM, Nati S, Marino G, Soracco M, Sertoli MR, Rubagotti A, Spriano M, Vassallo F, Rossi E, Vimercati R, Piaggio G, Figari O, Benvenuto F, Abate M, Truini M, Ravetti JL, Ribizzi I, Damasio E. Santini G, et al. Among authors: ribizzi i. Leuk Lymphoma. 1999 Apr;33(3-4):321-30. doi: 10.3109/10428199909058432. Leuk Lymphoma. 1999. PMID: 10221512 Clinical Trial.
Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori Group.
Queirolo P, Ponte M, Gipponi M, Cafiero F, Peressini A, Semino C, Pietra G, Lionetto R, Vecchio S, Ribizzi I, Melioli G, Sertoli MR. Queirolo P, et al. Among authors: ribizzi i. Ann Surg Oncol. 1999 Apr-May;6(3):272-8. doi: 10.1007/s10434-999-0272-4. Ann Surg Oncol. 1999. PMID: 10340886 Clinical Trial.
Analysis of the proliferative and phenotypic properties of tumor infiltrating lymphocytes expanded in vitro in the course of the clinical trial of adoptive immunotherapy of metastatic melanoma.
Pietra G, Semino C, Basso S, Gipponi M, Disomma G, Peressini A, Cafiero F, Ponte M, Queirolo P, Ribizzi I, Sertoli M, Melioli G. Pietra G, et al. Among authors: ribizzi i. Oncol Rep. 1997 Jan-Feb;4(1):27-31. doi: 10.3892/or.4.1.27. Oncol Rep. 1997. PMID: 21590006